cafead's Recent Activity
-
cafead posted a new thread.
Biogen: Don’t expect any big acquisitions this year
via While the company is eager to diversify beyond neuroscience, CEO Chris Viehbacher said that in the near-term any dealmaking would...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 9:52 PM -
cafead posted a new thread.
Boston Scientific's Farapulse Is a Showstopper
via Boston Scientific CEO Mike Mahoney says Farapulse, the company’s pulsed field ablation (PFA) system, is the most transformational...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 9:52 PM -
cafead posted a new thread.
Moderna partners with OpenAI to supercharge mRNA research with genAI
via Moderna announced a partnership with OpenAI, the company behind ChatGPT, to further incorporate AI across its mRNA drug development...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 9:32 PM -
cafead posted a new thread.
Biogen sees ‘encouraging’ trends for postpartum depression drug
via Biogen has seen “encouraging early trends” in the launch of its postpartum depression pill Zurzuvae, revealing in first quarter...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 9:32 PM -
cafead posted a new thread.
US Senate committee investigates pricing of Novo's Ozempic and Wegovy
via A U.S. Senate committee said on Wednesday it had launched an investigation into the prices of Novo Nordisk's (NOVOb.CO), opens new...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 9:32 PM -
cafead posted a new thread.
McKinsey faces US criminal probe over opioids work, sources say
via McKinsey & Co is under criminal investigation in the United States over allegations that the consulting firm played a key role in...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 9:32 PM -
cafead posted a new thread.
CureVac to cut costs in restructuring
via After a turbulent few years, German vaccine maker CureVac is retrenching with a plan to slim down its workforce and “streamline...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 9:32 PM -
cafead posted a new thread.
About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
via About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 10:22 AM -
cafead posted a new thread.
Biogen cost cuts drive profit beat, Alzheimer's drug sales jump
via Biogen (BIIB.O) beat market estimates for first-quarter profit on Wednesday as a series of cost-cutting measures helped offset the...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 10:22 AM -
cafead posted a new thread.
Roche Trims Four Early Assets as Q1 Sales Slip 6% on Currency, COVID Headwinds
via Roche released its first-quarter 2024 earnings results on Wednesday posting a 6% decline in sales compared to the same prior year...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 10:22 AM -
cafead posted a new thread.
BMS Initiates First Round of Layoffs in New Jersey
via Bristol Myers Squibb has resumed dismissing employees as part of an ongoing workforce reduction of about 10%. A WARN notice filed...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 10:22 AM -
cafead posted a new thread.
Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche
via The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. But, thanks to...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 9:12 AM -
cafead posted a new thread.
Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
via Day One Biopharmaceuticals on Tuesday announced that it has secured the FDA’s accelerated approval for tovorafenib, which will be...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 9:12 AM -
cafead posted a new thread.
Endeavor pulls in $132M to back cancer, lung disease drugs
via The funds will advance an idiopathic pulmonary fibrosis medicine once owned by Eli Lilly and an antibody-drug conjugate the startup...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 8:52 AM -
cafead posted a new thread.
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
via Demand is high for Eli Lilly’s Zepbound, and the weight-loss drug market could reach $100 billion by the end of the decade. But one...
Forum: Pharma/Biotech Companies - In the News
Apr 24, 2024 at 8:52 AM